Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
4658 results about "Absorbance" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
In chemistry, absorbance or decadic absorbance is the common logarithm of the ratio of incident to transmitted radiant power through a material, and spectral absorbance or spectral decadic absorbance is the common logarithm of the ratio of incident to transmitted spectral radiant power through a material. Absorbance is dimensionless, and in particular is not a length, though it is a monotonically increasing function of path length, and approaches zero as the path length approaches zero. The use of the term "optical density" for absorbance is discouraged. In physics, a closely related quantity called "optical depth" is used instead of absorbance: the natural logarithm of the ratio of incident to transmitted radiant power through a material. The optical depth equals the absorbance times ln(10).
Shock proof structure of battery pack for receiving battery cell
InactiveUS20120251861A1Simple structureUpgrades stabilityBattery isolationPortable power-driven toolsEngineeringAbsorbance
A shock proof structure of a battery pack for receiving a battery cell is formed in an electrical tool. The battery pack includes a base having a space for receiving the battery cell and a lid for opening or closing the space. The space has a plurality of first buckling portions separated by a gap disposed at a bottom side thereof. A plurality of second buckling portions with shock absorbance is formed at an inner sidewall of the lid. The plate sets include two plates separated by a gap are symmetrically positioned. The plates of each plate set have a second buckling portion with a stretching gap formed in between. The second buckling portion is positioned at the opposite end of the first buckling portion to provide the battery cell to be steadily buckled between the first and the second buckling portions.
Owner:DE POAN PNEUMATIC
Use of nanoparticulate organic pigments in paints and coatings
A protective and decorative coating composition including about 2 to 10 different colorants which in combination with a resinous composition produce a desired visible coating. A majority of the colorants has a maximum haze of about 10% and exhibits an absorbance peak in the visible spectrum wherein at least about 50% of the total absorbance in the visible spectrum occurs at wavelengths within about 50 nm of the wavelength of the peak absorbance.
Owner:PPG IND OHIO INC
Method for determination of analytes using NIR, adjacent visible spectrum and discrete NIR wavelenths
Described is a method for measuring the concentration of a blood constituent within a body part (80) of a living subject which comprises irradiating a body part of the subject with a continuum of a broad spectrum of radiation in adjacent and near infrared range of the electomagnetic spectrum; collecting the band of radiation after the radiation has been directed onto the part; dispersing the continuum of collected radiation into a dispersed spectrum of component wavelengths onto a detector (120) the detector taking measurements of at least one of transmitted or reflected radiation from the collected radiation; and transferring the measurements to a processor (300), and then measuring the same kind of absorbance or reflectance with respect to one or more a discrete wavelengths of radiation from the longer near infrared range and using the measurements to calculate the concentration of the constituent.
Owner:TYCO HEALTHCARE GRP LP
Process for preparing a polymer having a 2,5-furandicarboxylate moiety within the polymer backbone and such (CO)polymers
A process for preparing a polymer having a 2,5-furandicarboxylate moiety within the polymer backbone and having a number average molecular weight of at least 10,000 (as determined by GPC based on polystyrene standards) includes a first step where a prepolymer is made having the 2,5-furandicarboxylate moiety within the polymer backbone, followed in a second step by a polycondensation reaction. In the first step a 2,5-furandicarboxylate ester is transesterified with a compound or mixture of compounds containing two or more hydroxyl groups, in the presence of a tin(IV) based transesterification catalyst. In the second step at reduced pressure and under melt conditions the prepolymer prepared in the first step is polycondensed in the presence of a tin (II) based polycondensation catalyst until the polymer is obtained. This polymer may then be subjected to Solid State Polycondensation. Polymers so produced may have a 2,5-furandicarboxylate moiety within the polymer backbone, and having a number average molecular weight of at least 20,000 (as determined by GPC based on styrene standards), and an absorbance as a 5 mg / mL solution in a dichloromethane:hexafluoroisopropanol 8:2 at 400 nm of below 0.05.
Owner:FURANIX TECH BV
Device and method for monitoring body fluid and electrolyte disorders
InactiveUS7236811B2Improve measurement reliabilityDiagnostics using lightDiagnostics using pressureLipid formationTissue compartment
Owner:COVIDIEN LP
Raman-active taggants and their recognition
InactiveUS6610351B2Easy to useQuality improvementMaterial nanotechnologyRadiation applicationsMaximum dimensionActive component
An organic or organoelement, linear or branched, monomeric or polymeric composition of matter having a Raman-active component in the form of particles. The particles having a maximum dimension of 50 mum. The Raman-active compound is applied to a substrate. When the Raman-active compound is exposed to a laser light wavelength which is batochromically well beyond a spectral region of maximum absorbance of said Raman-active compound, Raman scattering can be detected.
Owner:QUANTAG SYST
Automatic analyzer
ActiveUS8043560B2High measurement accuracyLittle changeAnalysis using chemical indicatorsMicrobiological testing/measurementCuvetteAutoanalysis
An automatic analyzer using a reaction vessels of disposable type is provided which is compact in construction and with high accuracy of measurement.The analyzer is comprised with a reaction container which is capable of having a plurality of cuvettes of disposable type set therein, an extracting and injecting unit for injecting a first reagent, a specimen and a second reagent into a disposable cuvette, a light measuring unit for emitting light to the cuvette, and for measuring absorbance thereof and a CPU for producing a calculated value based on outputs of the light measuring unit.The light measuring unit measures absorbance of the first reagent, specimen and second reagent injected into and reacted with each other in a disposable cuvette, and also measures an air blank value representing absorbance of an empty disposable cuvette and a first reagent blank value representing absorbance of a disposable cuvette having first reagent in the cuvette (S104, S106). The CPU compensates the absorbance based on at least one of the air blank value and the first reagent blank value (S112, S113).
Owner:FURUNO ELECTRIC CO LTD
Pulse amplitude indexing method and apparatus
The invention is method and apparatus for determining a physiological characteristic by detecting the intensity of light following tissue absorption at two wavelengths, estimating the pulse amplitude and indexing a calculated physiological characteristic to the estimated pulse amplitude. In one embodiment, the ratio of logarithms of absorbance signal amplitude is indexed to the pulse amplitude to improve the accuracy of arterial oxygen saturation as determined by a pulse oximeter.
Owner:WOOLSTHORPE TECH
Raman-active taggants and their recognition
InactiveUS20020025490A1Easy to useQuality improvementOptical radiation measurementMaterial nanotechnologyLaser lightLasing wavelength
An organic or organoelement, linear or branched, monomeric or polymeric composition of matter having a Raman-active component in the form of particles. The particles having a maximum dimension of 50 mum. The Raman-active compound is applied to a substrate. When the Raman-active compound is exposed to a laser light wavelength which is batochromically well beyond a spectral region of maximum absorbance of said Raman-active compound, Raman scattering can be detected.
Owner:QUANTAG SYST
Raman-active taggants and thier recognition
InactiveUS20040058058A1Easy to useQuality improvementMaterial nanotechnologyRadiation pyrometryLasing wavelengthLaser light
Owner:SHCHEGOLIKHIN ALEXANDER NIKITOVICH +4
Topical macqui berry formulation
InactiveUS20070065396A1High ORACImprove antioxidant capacityBiocideCosmetic preparationsMedicineOxygen radical absorbance capacity
The present invention provides a topical formulation and method of use where the formulation comprises macqui berry or a macqui berry extract containing anthocyanins having a very high oxygen radical absorbance capacity (ORAC). The formulation provides the macqui berry in a stabilized form which includes a glucuronide or glycuronide, a photostabilizing agent, encapsulation, or light -and / or air-blocking packaging.
Owner:TRACIE MARTYN INT
Photovoltaic devices fabricated from insulating nanostructured template
Photovoltaic devices, such as solar cells, and methods for their manufacture are disclosed. A device may be characterized by an architecture with an inorganic insulating nanostructured template having template elements between about 1 nm and about 500 nm in diameter with a elements density of between about 1012 elements / m2 and about 1016 elements / m2. A first charge-transfer material coats the walls of the template elements leaving behind additional space. A second charge-transfer material fills the additional space such that the first and second charge-transfer materials are volumetrically interdigitated. At least one charge transfer material has an absorbance of greater than about 103 / cm. The first and second charge-transfer materials have complementary charge transfer properties with respect to each other. A lowest unoccupied molecular orbital (LUMO) or conduction band of the first charge-transfer material is offset from a LUMO or conduction band of the second charge-transfer material by greater than about 0.2 eV. An electrically conductive material may optionally be disposed between the nanostructured template and the first charge-transfer material.
Owner:AERIS CAPITAL SUSTAINABLE IP +1
Microfluidic systems with enhanced detection systems
ActiveUS7670559B2High sensitivitySludge treatmentFixed microstructural devicesChannel networkFluorescence
Microfluidic devices and systems having enhanced detection sensitivity, particularly for use in non-fluorogenic detection methods, e.g., absorbance. The systems typically employ planar microfluidic devices that include one or more channel networks that are parallel to the major plane of the device, e.g., the predominant plane of the planar structure, and a detection channel segment that is substantially orthogonal to that plane. The detection system is directed along the length of the detection channel segment using a detection orientation that is consistent with conventional microfluidic systems.
Owner:CAPLIPER LIFE SCI INC
Light emitting device and electronic appliance using the same
InactiveUS20060292394A1Easy to changeDistanceDischarge tube luminescnet screensElectroluminescent light sourcesVanadium oxideOrganic compound
A light emitting device comprises a pair of electrodes and a mixed layer provided between the pair of electrodes. The mixed layer contains an organic compound which contains no nitrogen atoms, i.e., an organic compound which dose not have an arylamine skeleton, and a metal oxide. As the organic compound, an aromatic hydrocarbon having an anthracene skeleton is preferably used. As such an aromatic hydrocarbon, t-BuDNA, DPAnth, DPPA, DNA, DMNA, t-BuDBA, and the like are listed. As the metal oxide, molybdenum oxide, vanadium oxide, ruthenium oxide, rhenium oxide, and the like are preferably used. Further, the mixed layer preferably shows absorbance per 1 μm of 1 or less or does not show a distinct absorption peak in a spectrum of 450 to 650 nm when an absorption spectrum is measured.
Owner:SEMICON ENERGY LAB CO LTD
Near infrared risk assessment of diseases
The present invention provides an apparatus and a method for identifying the risk of a clinical condition in a human or animal by correlating Near Infrared (NIR) absorbance spectral data with one or several parameters including a concentration of one or more substances in the skin, a concentration of one or more substances in skin plus subdermal tissue, a score derived from one or more clinical tests like a stress test on a treadmill, coronary angiography, or intravascular coronary ultrasound. The method determines the concentration of a compound in the skin of a human or animal and comprises the steps of placing a part of the skin against a receptor, directing electromagnetic radiation (EMR) from the near-infrared spectrum onto the skin, measuring a quantity of EMR reflected by, or transmitted through, the skin with a detector; and performing a quantitative mathematical analysis of the quantity of EMR to determine the concentration of the compound, for example free and esterfied cholesterol. An example of a clinical condition is cardiovascular disease.
Owner:TYCO HEALTHCARE GRP LP
OLED device with improved light output
InactiveUS20060250084A1High transparencyDecrease in light absorbanceDischarge tube luminescnet screensElectroluminescent light sourcesAbsorbanceTotal thickness
An organic light-emitting diode (OLED) device is described, comprising: a) a substrate; b) an OLED formed over the substrate comprising a first electrode, a partially transparent second electrode through which light from the OLED is emitted, and at least one layer of organic light-emitting material disposed between the first electrode and partially transparent second electrode; and c) an encapsulating layer deposited on the partially transparent second electrode, wherein the encapsulating layer comprises one or more component layers, and wherein the encapsulating layer and the partially transparent second electrode combined have a transparency greater than the transparency of the partially transparent second electrode in the absence of the encapsulating layer, or wherein the encapsulating layer and the partially transparent second electrode combined have an absorbance less than the absorbance of the partially transparent second electrode in the absence of the encapsulating layer. To provide adequate encapsulation, in accordance with various embodiments of the invention at least one component layer of the encapsulating layer is deposited by atomic layer deposition, or the total thickness of encapsulating layer is at least about 150 nm. In a preferred embodiment, both such features are incorporated.
Owner:EASTMAN KODAK CO
Photochromic articles with reduced temperature dependency and methods for preparation
InactiveUS7320826B2Improves antireflective nature of surfaceHigh light transmittanceOrganic chemistrySynthetic resin layered productsOptical densityAbsorbance
Described are photochromic articles that include a substrate, a temperature dependent reducing amount of at least one organic photochromic material (b) that changes from more absorbing to less absorbing of radiation in its activating spectral absorbance as the temperature increases from 10° C. to 35° C. and at least one other photochromic material (c) that is different from photochromic material (b). In the article, photochromic material (b) is interposed between photochromic material (c) and a source of activating radiation. The photochromic article demonstrates a more consistent photochromic response, for example, an optical density response loss of 50 percent or less over a temperature range of from 10° C. to 35° C. as measured in the Photochromic Temperature Dependence Test. Methods for producing the aforedescribed articles are also disclosed.
Owner:TRANSITIONS OPTICAL INC
Crystalline composition, wafer, and semi-conductor structure
ActiveUS20080008855A1Reduce defect levelConductive materialSolid-state devicesCrystallographySemiconductor structure
A crystalline composition is provided. The crystalline composition may include gallium and nitrogen; and the crystalline composition may have an infrared absorption peak at about 3175 cm−1, with an absorbance per unit thickness of greater than about 0.01 cm−1.
Owner:SLT TECH
Near infrared risk assessment of diseases
The present invention provides an apparatus and a method for identifying the risk of a clinical condition in a human or animal by correlating Near Infrared (NIR) absorbance spectral data with one or several parameters including a concentration of one or more substances in the skin, a concentration of one or more substances in skin plus subdermal tissue, a score derived from one or more clinical tests like a stress test on a treadmill, coronary angiography, or intravascular coronary ultrasound. The method determines the concentration of a compound in the skin of a human or animal and comprises the steps of placing a part of the skin against a receptor, directing electromagnetic radiation (EMR) from the near-infrared spectrum onto the skin, measuring a quantity of EMR reflected by, or transmitted through, the skin with a detector; and performing a quantitative mathematical analysis of the quantity of EMR to determine the concentration of the compound, for example free and esterfied cholesterol. An example of a clinical condition is cardiovascular disease.
Owner:TYCO HEALTHCARE GRP LP
Thermoplastic composites with improved sound absorbing capabilities
InactiveUS20060137799A1Alter its performanceOptimization propertiesWood working apparatusBaby linensGlass fiberPolyethylene terephthalate
A composite material formed of reinforcement fibers, acoustical enhancing fibers such as polyethylene terephthalate (PET) fibers or modified polyethylene terephthalate fibers, and one or more organic fibers is provided. The acoustical enhancing fiber may be any fiber that provides increased or enhanced acoustical absorbance, particularly at low frequencies. The composite material may be formed by partially opening wet reinforcing fibers, acoustical enhancing fibers, and organic fibers, mixing the reinforcing, acoustical enhancement, and organic fibers, forming the fibers into a sheet, and bonding the fibers in the sheet. Preferably the reinforcing fibers are wet use chopped strand glass fibers. The composite material may be formed of a single layer of reinforcement, acoustical enhancement fibers, and organic fibers. Alternatively, the composite material may be a multi-layered composite in which the acoustical enhancement fibers are located in an acoustical layer laminated to a thermal layer formed of the organic fibers and reinforcement fibers.
Owner:OWENS CORNING INTELLECTUAL CAPITAL LLC
VCSEL Tissue Spectrometer
In a tissue sensor, a plurality of emitters are configured to emit narrowband light into biological tissue at a plurality of selected wavelengths including one or more wavelengths indicative of a profile for one or more selected analytes and a reference wavelength at which absorbance for the selected analyte is negligible. The sensor further comprises a photo detector configured to detect light at wavelengths that emerge from the biological tissue.
Owner:NOSTIX
Method for determining analyte concentration using periodic temperature modulation and phase detection
InactiveUS6161028AThe process is convenient and fastExtreme accuracyRadiation pyrometryDiagnostics using lightContinuous measurementAnalyte
A method of determining the analyte concentration of a test sample is described. A temperature gradient is introduced in the test sample and infrared radiation detectors measure radiation at selected analyte absorbance peak and reference wavelengths. Reference and analytical signals are detected. In the presence of the selected analyte, parameter differences between reference and analytical signals are detectable. These parameter differences, having a relationship to analyte concentration, are measured, correlated, and processed to determine analyte concentration in the test sample. Accuracy is enhanced by inducing a periodically modulated temperature gradient in the test sample. The analytical and reference signals may be measured continuously and the parameter difference integrated over the measurement period to determine analyte concentration.
Owner:OPTISCAN BIOMEDICAL
Device and method for noninvasive continuous determination of physiologic characteristics
InactiveUS6921367B2Eliminate needEasy to take care ofElectrocardiographyEvaluation of blood vesselsHydrostatic pressureArrival time
The invention comprises devices for noninvasively monitoring physiological characteristics of a patient's blood. Generally, probes having radiation emitters and detectors are used to determine absorbance of blood within the patient's tissue to determine various blood parameters. The device also has either a position sensor for determining the position of the probe with respect to the patient's heart or a movement generator for altering the position of the probe with respect to the patient's heart. The invention also comprises methods for noninvasively monitoring the physiological characteristics. In one embodiemnt, induced positional changes create differential hydrostatic pressures to facilitate measurement of blood parameters by absorbance. In a second embodiment, delays in pulse arrival times in coupled organs or members on opposite sides of the body are measured to determine cardiac output. The two methods are such that they can advantageously be used together.
Owner:WOOLSTHORPE TECH
System and method for quantum based information transfer
A system for communicating data comprising sender and receiver subsystems; at least one data input; at least one entangled photon source; first photons of the pairs of entangled photons outputted by the at least one photon source being processed by one of the sender or receiver subsystem; second photons of the pairs of entangled photons being processed by the other of the sender or receiver subsystem; a photonic element configured to receive the first photons of the pairs of entangled photons and enable interference therebetween; at least one absorber configured to absorb the first photons after passage through the beam splitter, the absorbance of the first photons operating to transfer the properties of the entanglement to the second photons of the pairs of entangled photons; and a Bell state measurement element operatively associated with the receiver subsystem configured to measure the second photons of the pairs of entangled photons.
Owner:US SEC THE ARMY THE
Impact absorbing composites and their production
InactiveUS6425195B1Improve efficiencyImprove impact absorption performanceSolesLayered productsInternal pressureEngineering
An improved composite for absorbing and dispersing impacting forces is disclosed. The composite includes a flexible plastic enclosure defining an internal cavity. The flexible enclosure is generally impermeable to air and capable of having its internal pressure changed. The composite further includes a foam core filling the cavity and retained within the cavity and adhered on substantially all of its external surface to the internal surface of the cavity. The cavity can be pressurized for higher impact absorbance. Methods for fabricating the composites are disclosed, as well.
Owner:DONZIS BYRON A
Continuous spectroscopic measurement of total hemoglobin
ActiveUS7319894B2Fast informationEasy to readDiagnostics using spectroscopyCatheterPhotodetectorTotal hemoglobin
Methods for measuring the total hemoglobin of whole blood include measuring reflective light at multiple wavelengths within the visible spectrum, calculating light absorbance at each of the multiple wavelengths, performing a comparison in a change in like absorbance between the multiple wavelengths, and / or relating the comparison to total hemoglobin. A system for measuring total hemoglobin of whole blood may include at least one light source, a catheter, optical fibers, at least one photodetector, data processing circuitry, and / or a display unit.
Owner:EDWARDS LIFESCIENCES CORP
Sample collector
InactiveUS20090024060A1Easy to publishSimple samplingVaccination/ovulation diagnosticsDiagnostic recording/measuringAnalyteAbsorbent Pads
A collector includes a collecting element that receives a sample of bodily fluid. The collecting element may be an absorbent pad that has been treated with a surfactant to optimize recovery of analytes from the sample and / or their absorbance onto the absorbent material. An extractor is operably connected to a container and receives the collector to provide fluid communication between the collector and the container. The collector, when received by the extractor, is operable to release a volume of the sample into the container.
Owner:ORASURE TECHNOLOGIES
Nanoparticle comprising nanoshell of thickness less than the bulk electron mean free path of the shell material
InactiveUS7371457B2Increase polarizabilityGood optical performancePigmenting treatmentMaterial nanotechnologyParticulatesConductive materials
The present invention is for particulate compositions and methods for producing them that can absorb or scatter electromagnetic radiation. The particles are homogeneous in size and are comprised of a nonconducting inner layer that is surrounded by an electrically conducting material. The ratio of the thickness of the nonconducting layer to the thickness of the outer conducting shell is determinative of the wavelength of maximum absorbance or scattering of the particle. Unique solution phase methods for synthesizing the particles involve linking clusters of the conducting atoms, ions, or molecules to the nonconducting inner layer by linear molecules. This step can be followed by growth of the metal onto the clusters to form a coherent conducting shell that encapsulates the core.
Owner:RICE UNIV
Formulation and products for promoting skin cleanliness and health
InactiveUS20090155325A1Good for healthImprove skinBiocideCosmetic preparationsMedicinePersonal Care Product
The present disclosure generally relates to a formulation. More particularly, the formulation may be applied to skin and / or used in combination with a personal care product to improve absorbance and leakage control of the personal care product, and to promote a more positive feel and comfort through improved skin cleanliness and health.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Liquid crystal mixture with low negative dielectric
ActiveCN101698802ALow negative dielectric anisotropyReduce the driving voltageLiquid crystal compositionsSolubilityDisplay contrast
The invention relates to a liquid crystal mixture for a display, which comprises the following compounds in percentage by weight: 70 to 90 percent of compound in a general formula I, 0 to 20 percent of compound in a general formula II, 5 to 25 percent of compound in a general formula III, 0 to 10 percent of compound in a general formula IV and 1 to 15 percent of compound in a formula V. Through optimal combination and optical proportioning, the anisotropyenergy of the negative dielectric of the liquid crystal mixture reaches -9.5, a clearing point is between 95 and 110DEG C, the driving voltage is very low, the energy consumption can be effectively reduced, and a liquid crystal display (hereinafter referred to as LCD) powered by a battery is powered more durably. The mixture has good intersolubility between monomers, and the solubility of the mixture for dichroic dyes is good; and various single dichroic dyes with different colors can be added to the liquid crystal mixture, so the liquid crystal mixture has good absorbance and dichroic ratio to well realize darker dark state and greatly improve display contrast in the displaying process.
Owner:JIANGSU HECHENG DISPLAY TECHCO
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com